Webcast: Improving Life Science Companies Strategic Planning Process
A life science company's strategic planning process must be agile, completed at an appropriate level of detail, and scenario-based. An agile process allows the company to quickly evaluate changes in the business, such as an acquisition, introduction of a new product, or expansion into a new market. The appropriate level of detail means that the company can produce a strategic plan quickly and use aggregated product-level data integrated with source systems.
Scenario-based strategic plans evaluate multiple assumptions about key drivers, such as FDA approval stages, product volumes, and average selling prices, and report the effects of different assumptions on important metrics. Traditional methods for producing strategic plans do not adequately meet the needs of life science companies.
Learn about best practices in strategic planning and see a demonstration of the Strategic Modeling module of Oracle's Enterprise Planning and Budgeting Cloud Service (EPBCS). Ensure your company has the tools to capitalize on growth opportunities, reduce costs, and drive better decision making throughout the organization.
- Critical elements of a strategic planning process
- Discussion of existing solutions
- Demonstration of Strategic Modeling